Unlocking Clarity: How Psychedelic 5-MeO-DMT Mimics Meditation Brain States

A master meditator dedicated 15 years to mastering ego quieting. Brain scan studies indicate he may have utilized powerful psychedelics to attain an altered state.

“At low doses, there’s a significant overlap in brain activity between this psychedelic and non-dual meditative states,” explains Christopher Timmerman of University College London.

The realm of psychedelic research is expanding rapidly, revealing how substances like 5-MeO-DMT can enhance our understanding of consciousness and improve mental health. This compound, often sourced from North American toads, is particularly compelling due to its ability to rapidly disrupt mental processing without producing vivid visuals like other psychedelics.

Timmerman and his team conducted a detailed comparison between the altered states induced by 5-MeO-DMT and advanced meditation. They collaborated with lamas, experts in the Karma Kagyu tradition of Tibetan Buddhism, amassing over 54,000 hours of meditation data.

During three laboratory sessions, lamas meditated for 30 to 60 uninterrupted minutes, followed by either a placebo or varying doses of 5-MeO-DMT (5 or 12 milligrams). Their brain activity was meticulously measured during each scenario, alongside reports on their thoughts and sense of self post-session.

Findings revealed that low doses of 5-MeO-DMT (5 milligrams) created remarkable similarities in brain patterns to those observed during meditation. Both scenarios exhibited heightened alpha activity, which is often linked to a relaxed state, and a diminished response to external stimuli compared to placebo and baseline conditions. Gamma-ray activity, which relates to cognitive engagement, was also reduced.

Timmerman noted that while both experiences fostered a calm feeling where the lama’s thoughts “came and then vanished,” the meditative state offered a deeper sense of interconnectedness and mental clarity.

In contrast, higher doses (12 milligrams) of 5-MeO-DMT escalated gamma-ray activity, leaving the lama feeling entirely detached from his surroundings and even experiencing an overwhelming bright light. He remarked, “I’m not thinking about anything,” indicating a complete disconnect from awareness of his body and environment.

The higher dosage was linked to increased neuronal firing and entropy, suggesting overwhelming sensory input compared to both placebo and baseline conditions. Conversely, lower doses resulted in decreased neuronal firing and entropy.

Researchers state that these findings are pivotal in connecting neural pathways to the “collapse of the ego” and the sensation of “contentless consciousness.” However, variations in brain activity do not fully capture the lama’s subjective experiences, acknowledges Matthew Sachet from Harvard Medical School.

This study focused on a single seasoned meditator, indicating potential limitations in broader applicability, particularly given the variability in brain activity-related studies. Additionally, ensuring participants are blinded in psychedelic studies poses challenges due to the identifiable side effects of psychedelics; fortunately, lamas reported no such effects.

Nonetheless, Timmerman asserts that if future research confirms safe integration of 5-MeO-DMT enhances the benefits of advanced meditation, it may have significant implications for a wider audience. He is conducting ongoing research to explore if the drug can facilitate faster progress for newbies to meditation but strongly advises against unregulated home use, as 5-MeO-DMT remains illegal in many jurisdictions.

Meanwhile, Sachet suggests that those seeking the mental health advantages attributed to 5-MeO-DMT might find meditation a practical alternative, offering overlapping experiences without the risks of toxicity or addiction.